CEACAM1 thus marked unique types of immature and mature DC that were expanded within the tumor tissues and overlapped with PD1 and PD-L1 expression; the highest levels of CEACAM1 expression were present in treatment-resistant disease. This evidence concerns the gene PDCD1 and neoplasm.